Merck Czech Republic - Profits & Sales

Net Profit & Sales (CZK mil)
Pharmaceutical | Czech Republic | November 10, 2018
$2.99
Excel Sheet

Merck Czech Republic made a net profit of CZK 50.5 mil in 2017, up 21.7% when compared to the last year. Total sales reached CZK 1,818 mil, which is down 0.149% when compared to the previous year.

Historically, the company’s net profit reached an all time high of CZK 68.6 mil in 2015 and an all time low of CZK 1.98 mil in 2008.

In terms of sales, Merck Czech Republic reached an all time high of CZK 1,850 mil in 2015 and an all time low of CZK 514 mil in 2003.

Merck Czech Republic's net profit has grown -4.44% a year on average in the last five years while sales have increased by 0.715% a year since 2012.

The firm generated its shareholders an average return on invested capital of 8.69% in the last five years.

As far as Merck Czech Republic's peers are concerned, Bayer Czech Republic posted a net profit and sales of CZK 106 mil and CZK 4,180 mil in 2017 and Amgen Czech Republic generated a net profit of CZK 37.8 mil (with sales of CZK 417 mil).

You can see all the company’s data at Merck Czech Republic Profile, or you can download a report on the company in the report section.

Net Profit Unit 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic CZK mil 46.2 28.3 28.7 40.5 35.8
Bayer Czech Republic CZK mil 166 83.4 96.2 107 123
GlaxoSmithKline Czech Republic CZK mil 240 164 127 87.7 125
Merck Czech Republic CZK mil 49.3 63.4 27.4 34.9 68.6
Novartis Czech Republic CZK mil 41.7 50.0 52.3 82.2 82.7
Pfizer Czech Republic CZK mil 231 48.1 144 134 75.4
Roche Czech Republic CZK mil 50.5 38.7 135 94.9 51.0 ...
Sanofi-Aventis Czech Republic CZK mil 55.1 45.2 65.2 1.19 58.6
Servier Czech Republic CZK mil ... ... 12.8 13.6 13.6 15.9
Walmark CZK mil 214 -3.00 -8.61 41.8 -716
AVERAGE CZK mil 82.6 122 53.1 68.1 63.7 -7.96 58.2 65.9